Mastic and Increased Antioxidant Enzyme Levels

Doses used in studies

g/day: 2.1 (median 2.1, IQR 2.1–2.1) — 1 study

Time to effect

Median: 6 months · IQR 6 months–6 months · Range 6 months–6 months — Reported in 1 of 1 study

1 of 1 paper

Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD.

2021-05-07
RCT · n = 98
Frontiers in immunology 12
- Stavroula Kanoni
- Satish Kumar
- Charalampia Amerikanou
- Mary Jo Kurth
- Maria G Stathopoulou
- Stephane Bourgeois
- Christine Masson
- Aimo Kannt
- Lucia Cesarini
- Maria-Spyridoula Kontoe
- Maja Milanović
- Francisco J Roig
- Mirjana Beribaka
- Jonica Campolo
- Nuria Jiménez-Hernández
- Nataša Milošević
- Carlos Llorens
- Ilias Smyrnioudis
- M Pilar Francino
- Nataša Milić
- Andriana C Kaliora
- Maria Giovanna Trivella
- Mark W Ruddock
- Milica Medić-Stojanoska
- Amalia Gastaldelli
- John Lamont
- Panos Deloukas
- George V Dedoussis
- Sophie Visvikis-Siest

PubMed: 34025683
DOI: 10.3389/fimmu.2021.683028

5 Insights on

Increased Antioxidant Enzyme Levels

High evidence
Clinical

NAFLD patients with severe obesity (BMI > 35kg/m²) taking the Mastiha had significantly higher total antioxidant status (TAS) compared to the corresponding placebo group (P value=0.008).

Effect: Beneficial
Effect size: Moderate
Significant: Yes
Dose: 2.1 g/day